HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients. - Wikidata - awgldk - TriplyDB

HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients.

HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients.

http://www.wikidata.org/entity/Q33369144

about

Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility In vivo efficacy of shipped HLA-matched platelets.Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support?Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).Efficacy of HLA-matched platelet transfusions for patients with hypoproliferative thrombocytopenia: a systematic review.Persistence of recipient human leucocyte antigen (HLA) antibodies and production of donor HLA antibodies following reduced intensity allogeneic haematopoietic stem cell transplantation.Supportive care in patients with acute leukaemia: historical perspectives.A structurally based approach to determine HLA compatibility at the humoral immune level Determination of an unrelated donor pool size for human leukocyte antigen-matched platelets in Brazil HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors.Why can sensitization by an HLA-DR2 mismatch lead to antibodies that react also with HLA-DR1?Granulocyte transfusions in severe aplastic anemia: an eleven-year experience.Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications.HLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention and management.Platelet refractoriness--practical approaches and ongoing dilemmas in patient management.HLAMatchmaker is effective for selecting appropriate platelet units for alloimmunised thrombocytopaenic patients who are refractory to random donor platelets.Platelet donor selection for HLA-immunised patients; the impact of donor-specific HLA antibody levels.

P2860

Q26784256-EF86B1A3-7713-4C09-A053-C217E406BAA7 Q33372454-B0A7B239-2ED9-4EE8-9D92-2CF40C1578BF Q33377376-CA4F9472-BC35-45C6-9864-015C2921F4A9 Q33404137-3BD8A9D6-3C94-4D4E-99A3-07A3E4BB99D7 Q33406794-C015B874-088E-4F39-8FF6-AE9F5F58F510 Q34241347-31656481-92E6-442D-84F9-34E8AD525734 Q35265135-DC46C3AE-9B5E-481A-937A-421B903DC74A Q36316220-63649431-A00B-4D20-8611-2709206290A7 Q36674849-289BB4E5-0218-4D41-9D76-EB7EDBBC51BC Q36858319-0B7B0BC2-53A9-4354-A9BF-09B9000C1FEC Q36948245-4C1693AB-EE50-4A77-8D6B-6AE0E2D79E9D Q37300454-7DA2B2D9-19DB-4426-B2E7-AAC619CCE603 Q37470931-3EC6754D-B507-4763-A51F-B8AE2A9E180C Q37853627-77B47535-AD2C-4B0A-8BA0-ECCE699AF5F0 Q37990036-B54F51EA-8D08-457B-8AF0-E6BE3CB14092 Q38551094-8B4759AC-044D-4547-859B-4898C1C26A1B Q38844982-4077EA44-5DA9-48C8-9692-73602DF88CA7 Q40262642-309618FB-EC75-4065-9346-D99E2B64B9EC

P2860

HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients.

http://www.wikidata.org/entity/Q33369144

description

2005 nî lūn-bûn

@nan

2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

HLAMatchmaker-driven analysis ...... zed thrombocytopenic patients.

@ast

HLAMatchmaker-driven analysis ...... zed thrombocytopenic patients.

@en

type

label

HLAMatchmaker-driven analysis ...... zed thrombocytopenic patients.

@ast

HLAMatchmaker-driven analysis ...... zed thrombocytopenic patients.

@en

prefLabel

HLAMatchmaker-driven analysis ...... zed thrombocytopenic patients.

@ast

HLAMatchmaker-driven analysis ...... zed thrombocytopenic patients.

@en

P1433

Q33369144-3E0BDF75-6153-4DE5-AB80-E5D9811F2BBE

P1476

Q33369144-D7CA5E53-EC69-48A1-838B-3E068454B8CD

P2093

Q33369144-0D7DF2F4-C8D2-4F2E-A339-F3B333A6AC27

Q33369144-111B877C-FEF1-4D96-A7BC-5BC77C833561

Q33369144-30C17B9F-55B5-4667-AA24-EA22652F6CBB

Q33369144-B492A1FF-B0ED-4590-A4DE-63D2DEDE2D6D

Q33369144-B82CCCFA-8A8F-4886-869B-D7BE4634C81C

Q33369144-CA9EC7C2-AD7B-4984-95EF-2BA34644023C

Q33369144-D88C8CC7-8FCB-49C6-A11D-31244754FC97

Q33369144-F05B7A85-0B93-4BF0-A1BF-A28DE17EA680

P2860

Q33369144-039E54FF-F9BF-4D83-9E6C-196D1F727544

Q33369144-0EE56A2C-BEFE-4AE5-AA40-591964953EF1

Q33369144-137E864D-C6C2-4931-B4D9-42D24C92FBC3

Q33369144-2DC350CC-0F9E-4495-825E-FD0F55A7B4F0

Q33369144-304EB44B-F3D9-40A0-93A6-EC065275B206

Q33369144-41C78536-8BFE-4E9C-AE81-93ECF583EE38

Q33369144-61F42F3D-DEC9-412E-BB5B-427A87BBF9C6

Q33369144-62E4BC5E-7ECC-4375-B6BD-A641226F7B7E

Q33369144-6C55AF8F-54C4-4BB7-94B8-936A271E24C0

Q33369144-7063AC6F-3F95-415F-8B1C-A27EBC2A9CA8

P304

Q33369144-CB88D56C-EB8D-4967-89A0-F81055E987A6

P31

Q33369144-B366091C-1D53-4EF2-9F42-43C5F41A3B1E

P356

Q33369144-E9042B28-1B34-40DB-9594-5EC38B93214E

P407

Q33369144-07DF5C70-F838-467A-AD7F-E7A646881BF2

P433

Q33369144-153A6545-916D-4278-9F84-A6FF37BC5919

P478

Q33369144-94306F06-3F51-4583-85CD-3CA88D3DA955

P577

Q33369144-6FAEC16E-509D-4AA9-B0CE-99C0D886BC9C

P5875

Q33369144-BDEB544A-94E4-4CBE-BF9D-5834A3DBF181

P698

Q33369144-BF0B380C-7B8E-42D0-8139-3B5E72CD48DE

P921

Q33369144-969B9916-963F-4BBD-9273-1564E6D12911

P932

Q33369144-64D8378A-5CB8-4224-8CD0-6105D558D089

P356

BLOOD-2004-10-4080

P1433

P1476

HLAMatchmaker-driven analysis ...... zed thrombocytopenic patients.

@en

P2093

Ashok Nambiar

http://www.w3.org/2001/XMLSchema#string

David Stroncek

http://www.w3.org/2001/XMLSchema#string

Francesco Marincola

http://www.w3.org/2001/XMLSchema#string

Jaime Oblitas

http://www.w3.org/2001/XMLSchema#string

Rene J Duquesnoy

http://www.w3.org/2001/XMLSchema#string

Sharon Adams

http://www.w3.org/2001/XMLSchema#string

Susan Leitman

http://www.w3.org/2001/XMLSchema#string

Yingdong Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Ambiguous allele combinations in HLA Class I and Class II sequence-based typing: when precise nucleotide sequencing leads to imprecise allele identification

Measuring the accuracy of diagnostic systems

Selection of platelets for refractory patients by HLA matching and prospective crossmatching.

Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients.

Effect of HLA Bw4/Bw6 compatibility on platelet transfusion responses of refractory thrombocytopenic patients.

Platelet transfusion therapy. One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations.

Influence of clinical status on the efficiency of stored platelet transfusion.

Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets.

Diagnosis and management of refractoriness to platelet transfusion.

A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.

P304

1680-1687

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2004-10-4080

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2005-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7497715

http://www.w3.org/2001/XMLSchema#string

P698

16269623

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia

P932

1895402

http://www.w3.org/2001/XMLSchema#string